You just read:

NanoComposix expands its full-service lateral flow assay development services using novel ultra-sensitive nanoparticle reporters, covalent binding chemistry, and quantitative smartphone-based reader technologies to accelerate the development and optimization of lateral flow immunoassays

News provided by

nanoComposix

Jul 27, 2017, 11:07 ET